To overview |
|
| | |||
| Successful growth |
| Carl Zeiss Meditec shareholders approve high dividend | Downloads and Links | ||
 | RTF Documents
english (790 KB)Further Information 
Deutsche Version
| ||
| JENA/Germany, 10.03.2008. The shareholders of TecDAX-listed medical technology provider Carl Zeiss Meditec AG (ISIN: DE 0005313704) approved all items on the agenda of last Friday's General Meeting by clear majorities. This represented ongoing support for the company's many years of successful growth. A distribution of profits for the 2006/2007 financial year was also confirmed. Accordingly, Carl Zeiss Meditec will today pay a dividend of EUR 0.43, consisting of a regular dividend of EUR 0.16 and a special dividend of EUR 0.27. The dividend distribution corresponds to a dividend return of roughly 4.5%. In his speech at the General Meeting, Ulrich Krauss, President and CEO of Carl Zeiss Meditec AG, confirmed the Company's growth forecasts. The Company is predicting sales totalling between EUR 600 and 620 million in the current financial year 2007/2008. "Carl Zeiss Meditec will continue to increase its market share and its profitability in the future, through internal and external growth," said Krauss. "Our medium- term goal remains to achieve an EBIT margin of 14-15%," concluded Krauss. Patrick Kofler Director Investor Relations Phone: +49 3641 220-106 Fax: +49 3641 220-117 E-Mail: investors@meditec.zeiss.com Number: 0061-2008-ENG OP Number of Words: 181 Number of Signs: 1224 |
|